XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Previously Reported [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Common Stock [Member]
Recapitalization [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Previously Reported [Member]
Preferred Stock [Member]
Redeemable Convertible Preferred Stock [Member]
Recapitalization [Member]
Preferred Stock [Member]
Series F-1 [Member]
Additional Paid-in Capital [Member]
Additional Paid-in Capital [Member]
Previously Reported [Member]
Additional Paid-in Capital [Member]
Recapitalization [Member]
Accumulated Other Comprehensive Income Loss
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Recapitalization         $ 9             $ (9)      
Recapitalization Shares         54,236,376     111,831,592              
Beginning Balance at Mar. 31, 2019 $ (441,282) $ (441,282) $ 9 $ 0   $ 755,083 $ 755,083     $ 101,465 $ 101,474     $ (542,756) $ (542,756)
Beginning Balance, Shares at Mar. 31, 2019     96,159,892 41,923,516   198,274,933 86,443,341                
Issuance of common stock upon exercise of stock options 8,732                 8,732          
Issuance of common stock upon exercise of stock options, Shares     5,492,907                        
Vesting Early Exercised Stock Options 16,962                 16,962          
Stock-based compensation expense 45,568                 45,568          
Other comprehensive loss 0                            
Net loss (250,863)                         (250,863)  
Ending Balance at Mar. 31, 2020 (620,883) $ (45,568) $ 9     $ 755,083       172,727 $ 45,568     (793,619)  
Ending Balance, Shares at Mar. 31, 2020     101,652,799     198,274,933                  
Issuance of common stock upon exercise of stock options 29,092   $ 1             29,091          
Issuance of common stock upon exercise of stock options, Shares     11,768,079                        
Issuance of Series F-1 redeemable convertible preferred stock at $17.35 per share, net of issuance costs of $232                 $ 82,268            
Issuance of Series F-1 redeemable convertible preferred stock at $17.35 per share, net of issuance costs of $232, Shares                 10,906,922            
Issuance of common stock related to early exercise of stock options, shares     11,108,906                        
Vesting Early Exercised Stock Options 91,046   $ 2             91,044          
Stock-based compensation expense 88,745                 88,745          
Other comprehensive loss 0                            
Net loss (183,619)                         (183,619)  
Ending Balance at Mar. 31, 2021 (595,619)   $ 12     $ 837,351       381,607       (977,238)  
Ending Balance, Shares at Mar. 31, 2021     124,529,784     209,181,855                  
Preferred stock conversion 837,351   $ 21     $ (837,351)       837,330          
Preferred stock conversion, shares     (209,181,855)     209,181,855                  
Issuance of common stock for acquisition of business 322,845   $ 3             322,842          
Issuance of common stock for acquisition of business, Shares     30,572,268                        
Issuance of Common Stock for Class A Common Stock Warrant Exercise 42,356   $ 1             42,355          
Issuance of Common Stock for Class A Common Stock Warrant Exercise, Shares     6,016,347                        
Issuance of common stock upon Merger 200,579   $ 5             200,574          
Issuance Of Common Stock Upon Merger     46,901,747                        
Issuance of PIPE shares 250,000   $ 3             249,997          
Issuance of PIPE shares, shares     25,000,000                        
Issuance of common stock upon exercise of stock options $ 16,831                 16,831          
Issuance of common stock upon exercise of stock options, Shares 5,808,526   5,808,526                        
Vesting Early Exercised Stock Options $ 0                            
Stock-based compensation expense 58,624                 58,624          
Issuance of common stock upon release of RSUs     801,794                        
Other comprehensive loss 179                       $ 179    
Net loss (217,490)                         (217,490)  
Ending Balance at Mar. 31, 2022 $ 915,656   $ 45             $ 2,110,160     $ 179 $ (1,194,728)  
Ending Balance, Shares at Mar. 31, 2022     448,812,321